HCA Healthcare Inc (HCA) PT Lowered to $485 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mailGet Alerts HCA Hot Sheet
Price: $510.70 --0%
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
24 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
Goldman Sachs analyst Scott Fidel lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $485.00 (from $558.00) while maintaining a Buy rating.
You May Also Be Interested In
- HCA Healthcare Inc (HCA) PT Raised to $510 at Truist Securities
- HCA Healthcare proposes senior notes offering to refinance debt
- International Flavors & Fragrances (IFF) PT Raised to $95 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
